Concepedia

Carlota Tosat‐Bitrián

CT

Statistics

Publications

5

Citations

91

H-Index

5

Active since

2021

Affiliations

Instituto de Salud Carlos III(Current)

Centro de Investigaciones Biológicas Margarita Salas

Centro de Investigación Biomédica en Red

Biomedical Research Networking Center on Neurodegenerative Diseases

Madrid Institute for Advanced Studies

Carlota Tosat‐Bitrián is an author at Instituto de Salud Carlos III specializing in life sciences, kinase inhibitors, and neurodegeneration.

ORCID

Publications per year

2021–2024

5

Publications

5

Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles

Elisa Rojas‐Prats, Carlota Tosat‐Bitrián, Loreto Martínez‐González et al. · Pharmaceutics · 2021 · 22 citations · Full text

, , +17

From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis

Vanesa Nozal, Alfonso García‐Rubia, Eva P. Cuevas et al. · Angewandte Chemie International Edition · 2021 · 20 citations · Full text

, , +17

Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function

María A. Oliva, Carlota Tosat‐Bitrián, Lucía Barrado-Gil et al. · International Journal of Molecular Sciences · 2022 · 17 citations · Full text

, , +17

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients

Loreto Martínez‐González, Eva P. Cuevas, Carlota Tosat‐Bitrián et al. · Frontiers in Molecular Neuroscience · 2023 · 16 citations · Full text

, , +16

Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis

Eva P. Cuevas, Loreto Martínez‐González, Clara Gordillo et al. · Neurobiology of Disease · 2024 · 16 citations · Full text

, , +17

1–5 of 5